MONDAY, OCTOBER 23, 2017

Dengue protein controls human enzyme for replication fuel

Researchers find NS1 protein binds with GAPDH to speed up replication of virus. Read More »

Malaria, meningitis cases increase in Mali

Health officials in Mali recently announced that there has been a resurgence of malaria with multiple new meningitis cases throughout the region. Read More »

Single oral pill could be cure for malaria

A team of researchers at Portland State University (PSU) recently made a discovery that may result in a single oral pill that could cure malaria. Read More »

El Nino season connected to dengue fever epidemic

New research from an international team at the University of Pittsburgh Graduate School of Public Health shows that high temperatures in strong El Nino seasons are connected to dengue epidemics. Read More »

FDA clears Simplexa for 2015-2016 flu season

The United States Food and Drug Administration (FDA) recently cleared the Focus Diagnostics Simplexa Flu A/B & RSV Direct Test to identify a total of 92 influenza as well as respiratory syncytial virus strains. Read More »

Suspected MERS-CoV case shows negative test results

The Center for Health Protection (CHP), a branch of the Department of Health (DH), recently announced that it has received negative test results from a suspected Middle East Respiratory Syndrome (MERS) case. Read More »

Bangkok hosts international vaccine manufacturers meeting

Bangkok recently hosted the Organizing Committee of the 16th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) from Oct. 5 to 7, 2015. Read More »

New research reveals improved TB detection methods in Cambodia

New research from Phnom Penh slums, where tuberculosis (TB) is especially prominent, shows that a more effective method of detecting TB cases may be accomplished with strong local community involvement and novel diagnostic tools. Read More »

Emergency committee updates WHO on West Africa's Ebola outbreak

The International Health Regulations Emergency Committee discussed the Ebola virus disease (EVD) outbreak in West Africa on Oct. 1 at its seventh meeting, which was called by the World Health Organization's (WHO) director-general. Read More »

Study finds HIV particles trapped more effectively by certain cervicovaginal mucus

Findings of a recent study indicating that HIV particles are more effectively trapped by the cervicovaginal mucus (CVM) in women who harbor the vaginal bacteria species Lactobacillus crispatus were published Tuesday in mBio, the open access journal of the American Society for Microbiology (ASM).  Read More »

U.S. Department of Health funds novel methods of improving influenza vaccines

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently provided sponsorship of two novel approaches to improving influenza vaccines. Read More »

PPD receives pharmaceutical product development research contracts

Pharmaceutical Product Development LLC (PPD) recently announced that it has accepted two different U.S. government contracts from the U.S. Army and from BARDA to further research and develop pharmaceutical products. Read More »

U. of Nottingham studies crucial to large flu drug report

A large new national report about the use of neuraminidase inhibitors, or antiviral drugs, to prevent and treat influenza has used studies from The University of Nottingham to establish its facts. Read More »

Vaxart to present influenza tablet vaccine data

Vaxart Inc., a privately held clinical-stage biotechnology company that creates oral recombinant vaccines in the form of tablets instead of injections, recently announced that its representatives will present data from its phase 1 study. Read More »

Influenza vaccination coverage expanded to elderly and intellectually disabled

Dr. Leung Ting-hung, Controller of the Center for Health Protection (CHP) of the Hong Kong Department of Health (DH), recently announced that free influenza vaccination coverage has been expanded to include all people 65 years old or older as well as persons with intellectual disabilities (PIDs). Read More »

GSK, Pfizer finalize meningitis assets transaction

GlaxoSmithKline (GSK) and Pfizer recently announced that they have successfully finalized their transaction of Nimenrix and Mencevax, both of which are meningitis assets. Read More »

New partnership provides South Africa with vaccines

A new partnership between Cipla Medpro (Pty) Ltd, a worldwide pharmaceutical company with cutting edge innovation and technology to meet patients' needs, and Serum Institute India (SII), the world’s biggest vaccine manufacturer, will provide South Africa with vaccines. Read More »

Hong Kong releases dengue fever update

The Center for Health Protection (CHP), a branch of the Department of Health (DH), recently released the latest update about the number of dengue fever cases in Hong Kong. Read More »

Immunization campaign guarantees childhood vaccinations in Timor-Leste

An immunization campaign in Timor-Leste targets children living in remote areas who have not received their vaccinations by increasing the coverage rate and the capacity of various national health institutions. Read More »

Univ. of Maryland launches clinical trial of HIV vaccine candidate

While at the University of Maryland (UMD) School of Medicine's Institute of Human Virology, Maryland Lt. Gov. Boyd Rutherford announced the institute has started Phase 1 clinical trial of its new HIV vaccine candidate. Read More »